Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 800 results for "sandoz inc"

Supreme Court Preview -- Teva Pharmaceuticals USA, Inc. v. San...

The Supreme Court will begin its 2014-2015 term next Monday. Last year, the Court heard a record number of patent law cases, at least for recent history. Nevertheless, it is scheduled to hear another one on October 15. Teva Pharmaceuticals USA, Inc. JD Supra, 16 hours ago
Supreme Court corner - September, 2014 Lexology, 2 weeks ago

1 images for "sandoz inc"

New Jersey Online, 2 months ago

Orion announces amended settlement agreement over the proprietary drug Precedex(R)

at 6.20 p.m. EEST Orion Corporation ("Orion") together with Hospira, Inc. ("Hospira") and Sandoz Inc. and Sandoz Canada Inc. (hereinafter collectively "Sandoz") have amended the settlement agreement published on 5 December 2013 regarding the market ...
 Individual.com1 week ago REG-Orion announces amended settlement agreement over the proprietary drug Precedex(R)  Reuters1 week ago
[x]  

Novartis AG's Sandoz, Inc. Will Move Into Former Novo Nordisk A/S Headquarters In New Jersey

PLAINSBORO — The former home of Novo Nordisk, a Danish pharmaceutical company that has sat vacant along Route 1 for more than a year, will soon have a new tenant and new job opportunities. Sandoz Inc., a major pharmaceutical company that ...
 BioSpace1 day ago

Novartis : CONTRACT AWARD - 65-- Oxazepam Capsules Sandoz, Inc Effective: 9/22/2014 - 9/21/2015 (+ 4 one year options)

Notice Type: CONTRACT AWARD Posted Date: 12-SEP-14 Office: VA National Acquisition Center Location: DEPARTMENT OF VETERANS AFFAIRS NATIONAL ACQUISITION CENTER Office Address: DEPARTMENT OF VETERANS AFFAIRS , VA NATIONAL ACQUISITION ...
 4 Traders2 weeks ago

Apricus Biosciences To Present At The 13th Annual BIO Investor Forum

SAN DIEGO, Oct. 1, 2014 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines to meet the needs of patients, today announced that Richard Pascoe, Chief Executive Officer, will present ...
 TheStreet.com34 minutes ago APRICUS BIOSCIENCES : to Present at the 13th Annual BIO Investor Forum  4 Traders29 minutes ago
[x]  

PharmaDerm launches onychomycosis medication in US

PharmaDerm, a dermatology business of Sandoz, has launched KERYDIN topical solution, 5%, for the treatment of onychomycosis of the toenails, in US. KERYDIN is developed by Anacor Pharmaceuticals, Inc. In July 2014, Sandoz announced an agreement with ...
 Individual.com4 days ago Anacor's Kerydin Launched in the US for Onychomycosis  Yahoo! Finance1 week ago Anacor Announces U.S. Launch Of KERYDIN Topical Solution, 5%  RTTNews.com1 week ago
New Jersey Law Journal

Unapproved Opinions: September 11-17, 2014

STATE COURT CASES BUSINESS ENTITIES 12-2-5235 Seven Caesars, Inc. v. Dooley House, App. Div. (per curiam) (31 pp.) The question before the court is whether a foreign corporation whose certificate of authority to conduct business in New Jersey ...
 New Jersey Law Journal1 week ago

Latisse Appeal, Scottish Web: Intellectual Property

Allergan Inc. In a notice published on its website Sept. 12, the court rejected a petition to reconsider its June invalidation of their patents. The rulings clear the way for generic versions of Latisse to enter the market. In June, the Federal ...
 BusinessWeek2 weeks ago

Sandoz donates penicillin for Rheumatic Heart Disease research

Rheumatic heart disease (RHD) is a silent killer that is still prevalent in developing countries. A new study by the Novartis Institutes for BioMedical Research (NIBR), which uses Sandoz-donated, life-saving penicillin, aims to address RHD among ...
 Biz Community3 weeks ago Novartis : Sandoz donates penicillin for Rheumatic Heart Disease research  4 Traders3 weeks ago
SPi World News

Fitch Affirms Amgen's IDR at 'BBB'; Outlook Remains Negative

CHICAGO--(BUSINESS WIRE)-- Fitch Ratings has affirmed the ratings for Amgen Inc. (Amgen) including Amgen's 'BBB'/'F2' Issuer Default Rating (IDR). The Rating Outlook remains Negative. A full list of rating actions follows at the end of this press ...
 CNBC3 weeks ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less